書誌情報

PS-2. Amivantamab (JNJ-61186372), an EGFR-MET bispecific antibody, for EGFR Exon20ins-mutated NSCLC

Koichi Goto1, Yuichiro Ohe2, Toyoaki Hida3, Hiroshi Tanaka4, Thomas John5, Sang-We Kim6, Jong-Seok Lee7, Catherine A. Shu8, Dong-Wan Kim9, Santiago Viteri Ramirez10, Alexander I. Spira11, Joshua K. Sabari12, Chee Khoon Lee13, Meena Thayu14, Roland E. Knoblauch14, Byoung Chul Cho15, Keunchil Park16
1National Cancer Center Hospital East, 2National Cancer Center Hospital, 3Aichi Cancer Center Hospital, 4Niigata Cancer Center Hospital, 5Austin Hospital, 6Asan Medical Center, 7Seoul National University Bundang Hospital, 8Columbia University Medical Center, 9Seoul National University Hospital, 10Hospital Universitari Dexeus, 11Virginia Cancer Specialists, 12New York University School of Medicine, 13St George Hospital, 14Janssen R & D, Spring House, 15Yonsei Cancer Center, Yonsei University College of Medicine, 16Samsung Medical Center, Sungkyunkwan University School of Medicine
Japanese Journal of Lung Cancer 60(6): 448-448, 2020.

個人会員・法人会員の方(IDが5または10で始まる方)

  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。

ライブラリー会員の方(IDが11または12で始まる方)